初筛反应性献血者确证方案与归队策略分析  

Analysis on strategy of confirmatory tests and reentry for donors screened reactive

作　　者：李玲[1] 刘忠[1] 

机构地区：[1]中国医学科学院北京协和医学院输血研究所,四川成都610052

出　　处：《中国输血杂志》2016年第1期1-2,共2页Chinese Journal of Blood Transfusion

基　　金：2013年国家卫生和计划生育委员会委托项目;协和青年基金(3332015121)

摘　　要：目前我国初筛反应性的献血者仍然都被永久性屏蔽,一方面被屏蔽原因中存在的检测假阳性结果会引起献血者的反感,造成一些不必要的社会问题;另一方面检测假阳性结果导致当事献血者被永久淘汰,使我国的无偿献血丧失了一部分宝贵的血源,客观上也对临床血液的供应不足产生了一定的影响。因而对初筛反应性的献血者做确证,使初筛假阳性献血者能够回归献血人群(规队),这对保护献血者的权益和缓解血液供应紧张的局面都具有重要意义。本专题对不同病原体的筛查方法和确证结果作了分析,初步探讨了各类初筛反应性献血者的确证方案和归队策略。The current national regulation requires that blood donors who are reactive at the initial screening must be permanently deferred from blood donation. On the one hand,the problem of false positives caused donors doubts and resentment. On the other hand,the permanent deferral of false positives donors could reduce the numbers of blood donors in our country,which could affect blood supply. It is extremely important to confirm by screening reactive blood donors,so that false-positive blood donor can return to donate blood. In the long term,their rights and interests will be protected and blood shortage can be resolved. This article analyzes the screening strategies and confirmatory tests for different pathogens,and studies confirmatory and reentry strategies for false positive blood donors.

关 键 词：献血者归队 献血者屏蔽 病原体筛查 反应性 假阳性 确证试验 

分 类 号：R446[医药卫生—诊断学] R457.1[医药卫生—临床医学]